MENU

BEAM Beam Therapeutics Forecast, Technical & Fundamental Analysis

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

BEAM is expected to report earnings to fall 7.81% to -117 cents per share on March 02

Beam Therapeutics BEAM Stock Earnings Reports
Q4'26
Est.
$-1.18
Q3'26
Missed
by $0.11
Q2'26
Missed
by $0.08
Q1'26
Beat
by $0.12
Q4'25
Beat
by $3.34
The last earnings report on November 03 showed earnings per share of -127 cents, missing the estimate of -116 cents. With 1.72M shares outstanding, the current market capitalization sits at 2.73B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TTXD14.570.31
+2.20%
Direxion Daily Technology Top 5 Bear 2X ETF (TTXD)
FUMB20.06-0.02
-0.07%
First Trust Ultra Short Duration Municipal ETF (FUMB)
FFEB62.27-0.12
-0.19%
FT Vest U.S. Equity Buffer Fund - February (FFEB)
PPTY33.30-0.13
-0.40%
US Diversified Real Estate ETF (PPTY)
BPRO18.84-0.52
-2.69%
Bitwise Proficio Currency Debasement ETF (BPRO)

BEAM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.31%
CRSP - BEAM
77%
Closely correlated
-0.06%
EDIT - BEAM
67%
Closely correlated
+7.00%
NTLA - BEAM
67%
Closely correlated
+6.70%
PRME - BEAM
65%
Loosely correlated
-7.53%
RXRX - BEAM
60%
Loosely correlated
+8.10%
More

Groups containing BEAM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.31%
BEAM
(4 stocks)
91%
Closely correlated
-8.34%
A.I. Advisor
published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
511
Web
https://www.beamtx.com
Beam Therapeutics (BEAM) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com